LRRK2相关帕金森病外显率的分子机制

IF 0.8 4区 生物学 Q4 GENETICS & HEREDITY
Medizinische Genetik Pub Date : 2022-08-12 eCollection Date: 2022-06-01 DOI:10.1515/medgen-2022-2127
Joanne Trinh, Emma L Schymanski, Semra Smajic, Meike Kasten, Esther Sammler, Anne Grünewald
{"title":"LRRK2相关帕金森病外显率的分子机制","authors":"Joanne Trinh, Emma L Schymanski, Semra Smajic, Meike Kasten, Esther Sammler, Anne Grünewald","doi":"10.1515/medgen-2022-2127","DOIUrl":null,"url":null,"abstract":"<p><p>Mutations in <i>Leucine-rich repeat kinase 2</i> (<i>LRRK2</i>) are the most frequent cause of dominantly inherited Parkinson's disease (PD). <i>LRRK2</i> mutations, among which p.G2019S is the most frequent, are inherited with reduced penetrance. Interestingly, the disease risk associated with <i>LRRK2</i> G2019S can vary dramatically depending on the ethnic background of the carrier. While this would suggest a genetic component in the definition of <i>LRRK2</i>-PD penetrance, only few variants have been shown to modify the age at onset of patients harbouring <i>LRRK2</i> mutations, and the exact cellular pathways controlling the transition from a healthy to a diseased state currently remain elusive. In light of this knowledge gap, recent studies also explored environmental and lifestyle factors as potential modifiers of <i>LRRK2</i>-PD. In this article, we (i) describe the clinical characteristics of <i>LRRK2</i> mutation carriers, (ii) review known genes linked to <i>LRRK2</i>-PD onset and (iii) summarize the cellular functions of <i>LRRK2</i> with particular emphasis on potential penetrance-related molecular mechanisms. This section covers <i>LRRK2</i>'s involvement in Rab GTPase and immune signalling as well as in the regulation of mitochondrial homeostasis and dynamics. Additionally, we explored the literature with regard to (iv) lifestyle and (v) environmental factors that may influence the penetrance of <i>LRRK2</i> mutations, with a view towards further exposomics studies. Finally, based on this comprehensive overview, we propose potential future <i>in vivo</i>, <i>in vitro</i> and <i>in silico</i> studies that could provide a better understanding of the processes triggering PD in individuals with <i>LRRK2</i> mutations.</p>","PeriodicalId":48632,"journal":{"name":"Medizinische Genetik","volume":"34 1","pages":"103-116"},"PeriodicalIF":0.8000,"publicationDate":"2022-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11006382/pdf/","citationCount":"0","resultStr":"{\"title\":\"Molecular mechanisms defining penetrance of <i>LRRK2</i>-associated Parkinson's disease.\",\"authors\":\"Joanne Trinh, Emma L Schymanski, Semra Smajic, Meike Kasten, Esther Sammler, Anne Grünewald\",\"doi\":\"10.1515/medgen-2022-2127\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Mutations in <i>Leucine-rich repeat kinase 2</i> (<i>LRRK2</i>) are the most frequent cause of dominantly inherited Parkinson's disease (PD). <i>LRRK2</i> mutations, among which p.G2019S is the most frequent, are inherited with reduced penetrance. Interestingly, the disease risk associated with <i>LRRK2</i> G2019S can vary dramatically depending on the ethnic background of the carrier. While this would suggest a genetic component in the definition of <i>LRRK2</i>-PD penetrance, only few variants have been shown to modify the age at onset of patients harbouring <i>LRRK2</i> mutations, and the exact cellular pathways controlling the transition from a healthy to a diseased state currently remain elusive. In light of this knowledge gap, recent studies also explored environmental and lifestyle factors as potential modifiers of <i>LRRK2</i>-PD. In this article, we (i) describe the clinical characteristics of <i>LRRK2</i> mutation carriers, (ii) review known genes linked to <i>LRRK2</i>-PD onset and (iii) summarize the cellular functions of <i>LRRK2</i> with particular emphasis on potential penetrance-related molecular mechanisms. This section covers <i>LRRK2</i>'s involvement in Rab GTPase and immune signalling as well as in the regulation of mitochondrial homeostasis and dynamics. Additionally, we explored the literature with regard to (iv) lifestyle and (v) environmental factors that may influence the penetrance of <i>LRRK2</i> mutations, with a view towards further exposomics studies. Finally, based on this comprehensive overview, we propose potential future <i>in vivo</i>, <i>in vitro</i> and <i>in silico</i> studies that could provide a better understanding of the processes triggering PD in individuals with <i>LRRK2</i> mutations.</p>\",\"PeriodicalId\":48632,\"journal\":{\"name\":\"Medizinische Genetik\",\"volume\":\"34 1\",\"pages\":\"103-116\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2022-08-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11006382/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medizinische Genetik\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1515/medgen-2022-2127\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/6/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medizinische Genetik","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1515/medgen-2022-2127","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

摘要

摘要富含亮氨酸重复激酶2(LRRK2)的突变是显性遗传性帕金森病(PD)最常见的病因。LRRK2突变,其中p.G2019S是最常见的,是外显率降低的遗传性突变。有趣的是,与LRRK2 G2019S相关的疾病风险可能因携带者的种族背景而异。虽然这表明LRRK2-PD外显率的定义中存在遗传成分,但只有少数变体被证明可以改变携带LRRK2突变的患者的发病年龄,而控制从健康状态向疾病状态转变的确切细胞途径目前仍然难以捉摸。鉴于这一知识差距,最近的研究还探讨了环境和生活方式因素作为LRRK2-PD的潜在调节剂。在这篇文章中,我们(i)描述了LRRK2突变携带者的临床特征,(ii)综述了与LRRK2-PD发病有关的已知基因,(iii)总结了LRRK2-的细胞功能,特别强调了潜在的外显率相关分子机制。本节介绍LRRK2参与Rab GTPase和免疫信号传导,以及线粒体稳态和动力学的调节。此外,我们探索了关于(iv)生活方式和(v)可能影响LRRK2突变外显率的环境因素的文献,以期进行进一步的暴露组学研究。最后,基于这一全面综述,我们提出了未来潜在的体内、体外和计算机研究,这些研究可以更好地了解LRRK2突变个体触发PD的过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Molecular mechanisms defining penetrance of LRRK2-associated Parkinson's disease.

Mutations in Leucine-rich repeat kinase 2 (LRRK2) are the most frequent cause of dominantly inherited Parkinson's disease (PD). LRRK2 mutations, among which p.G2019S is the most frequent, are inherited with reduced penetrance. Interestingly, the disease risk associated with LRRK2 G2019S can vary dramatically depending on the ethnic background of the carrier. While this would suggest a genetic component in the definition of LRRK2-PD penetrance, only few variants have been shown to modify the age at onset of patients harbouring LRRK2 mutations, and the exact cellular pathways controlling the transition from a healthy to a diseased state currently remain elusive. In light of this knowledge gap, recent studies also explored environmental and lifestyle factors as potential modifiers of LRRK2-PD. In this article, we (i) describe the clinical characteristics of LRRK2 mutation carriers, (ii) review known genes linked to LRRK2-PD onset and (iii) summarize the cellular functions of LRRK2 with particular emphasis on potential penetrance-related molecular mechanisms. This section covers LRRK2's involvement in Rab GTPase and immune signalling as well as in the regulation of mitochondrial homeostasis and dynamics. Additionally, we explored the literature with regard to (iv) lifestyle and (v) environmental factors that may influence the penetrance of LRRK2 mutations, with a view towards further exposomics studies. Finally, based on this comprehensive overview, we propose potential future in vivo, in vitro and in silico studies that could provide a better understanding of the processes triggering PD in individuals with LRRK2 mutations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medizinische Genetik
Medizinische Genetik Medicine-Genetics (clinical)
CiteScore
1.40
自引率
9.10%
发文量
48
审稿时长
>12 weeks
期刊介绍: medizinischegenetik is a scientific journal that is owned and published by the German Society of Human Genetics e.V. since 1989. The journal was founded by Prof. Jan Murken, München. Self-published until 2006, from 2007-2019 published at Springer Verlag and since 2020 at De Gruyter. medizinischegenetik serves education and training among colleagues, the interdisciplinary exchange of knowledge in all areas of human genetics in clinics, practice, research and teaching. Each issue of the quarterly journal deals with a focus that provides a comprehensive overview of current developments in specific clinical pictures, technical developments and therapeutic approaches. All reviews are written in English language. The journal thus creates a platform for the international exchange of knowledge and increased awareness of German research activities in the scientific community. In addition, medizinischegenetik contains information on activities in its own subject in the German-language section. This includes conference reports, association announcements, personnel matters, statements and guidelines. With health policy questions, historical retrospectives and comments on current developments, the profession takes a stand on human genetic issues in Germany, Austria and Switzerland.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信